Publication dates

Leukemia Industry, July 2014 Market Reports from Top Publishers

You might be interested in: cancer, nucleic acid testing, flow cytometry, more »


 
1-10 of about 200 reports for Leukemia

Leukemia Drug Pipeline Update 2014

Leukemia Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

... leukemia drug pipeline update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 277 different targets. All included targets have been cross ...

Leukemia Drug Pathway Analyzer 2014

Leukemia Drug Pathway Analyzer 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

... Before. Its capabilities moves you beyond powerful competitive intelligence to an opportunity seeking tool which lets you, by means of both present and emerging scientific knowledge, analyze the leukemia ...

 Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • July 2014
  • by Delve Insight

... leukemia (aml, acute myeloblastic leukemia) key products to exploit opportunities for generic drug development opportunities. - Identify and understand important and diverse types of therapeutics under ...

 B-Cell Chronic Lymphocytic Leukemia Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

B-Cell Chronic Lymphocytic Leukemia Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • July 2014
  • by Delve Insight

... Counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to b-cell chronic lymphocytic leukemia. - Api intelligence over marketed drugs ...

 T-Cell Leukemia Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

T-Cell Leukemia Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • July 2014
  • by Delve Insight

... Cell leukemia key products to exploit opportunities for generic drug development opportunities. - Identify and understand important and diverse types of therapeutics under phase iii development for t ...

 Leukemias Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Leukemias Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • July 2014
  • by Delve Insight

... Global sales figure from 2011-2015.Reasons to buy - evaluate the marketing status and exclusivity details of leukemias key products to exploit opportunities for generic drug development ...

 Meningeal Leukemia Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Meningeal Leukemia Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • July 2014
  • by Delve Insight

... Of meningeal leukemia key products to exploit opportunities for generic drug development opportunities. - Identify and understand important and diverse types of therapeutics under phase iii development ...

OpportunityAnalyzer: Chronic Lymphocytic Leukemia - Opportunity Analysis and Forecasts to 2018

OpportunityAnalyzer: Chronic Lymphocytic Leukemia - Opportunity Analysis and Forecasts to 2018

  • $ 5 995
  • Industry report
  • June 2014
  • by Global Data

... Efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships. Opportunityanalyzer: chronic lymphocytic leukemia ...

The Leukemia & Lymphoma Society, Inc. - Strategic SWOT Analysis Review

The Leukemia & Lymphoma Society, Inc. - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • June 2014
  • by Global Data

... Or business research. - Key elements such as swot analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs. The leukemia & lymphoma society, inc ...

 Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • June 2014
  • by Delve Insight

... Acute lymphoblastic leukemia) key products to exploit opportunities for generic drug development opportunities. - Identify and understand important and diverse types of therapeutics under phase iii ...

About 1 800 reports for Leukemia

Download Unlimited Documents from Trusted Public Sources

Agrochemical Industry in Brazil

  • In Utero Pesticide Exposure and Leukemia in Brazilian Children <...
  • January 2012
    7 pages
  • Leukemia  

    Cancer  

  • Brazil  

    South America  

View report >

11 Companies for Leukemia

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Novartis Inc.

Switzerland

Celgene Corp.

United States

GlaxoSmithKline PLC

United Kingdom

Pfizer Inc.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.